- 全部删除
 
您的购物车当前为空
DNDI-6148 具有抗实验性皮肤利什曼病活性,通过抑制利什曼原虫裂解和多聚腺苷酸化特异性因子 (CPSF3) 核酸内切酶起作用,可用于研究内脏利什曼病。


为众多的药物研发团队赋能,
让新药发现更简单!
DNDI-6148 具有抗实验性皮肤利什曼病活性,通过抑制利什曼原虫裂解和多聚腺苷酸化特异性因子 (CPSF3) 核酸内切酶起作用,可用于研究内脏利什曼病。
| 规格 | 价格 | 库存 | 数量 | 
|---|---|---|---|
| 1 mg | ¥ 1,180  | In stock | |
| 2 mg | ¥ 1,770  | In stock | |
| 5 mg | ¥ 2,950  | In stock | |
| 10 mg | ¥ 4,270  | In stock | |
| 25 mg | ¥ 6,360  | In stock | 
DNDI-6148 相关产品
| 产品描述 | DNDI-6148 has anti-experimental cutaneous leishmaniasis activity and can be used to study visceral leishmaniasis by inhibiting Leishmania protozoa cleavage and polyadenylation-specific factor (CPSF3) endonuclease.  | 
| 分子量 | 335.13 | 
| 分子式 | C16H14BN5O3 | 
| CAS No. | 2243909-59-1 | 
| Smiles | O=C(NC1=CC=C2C(=C1)B(O)OC2)C=3N=NN(C4=NC=CC=C4)C3C | 
| 密度 | no data available | 
| 颜色 | Yellow | 
| 物理性状 | Solid | 
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | 
评论内容